T h e best known family B, or Type 11, G-proteincoupled receptors (GPCRs) recognize peptides as ligands. T h e receptors for corticotrophinreleasing factor, parathyroid hormone and secretin typify this group. However, there are only 15 such GPCRs. Many other receptors share sequence homology and have been assigned to this family.
Introduction
Now that the sequencing of the human genome is essentially complete, we know its complement of G-protein-coupled receptors (GPCRs). There are approx. 350 non-sensory GPCRs, of which 270 are in family A (type I ; rhodopsin-like), 65 in family B (type I1 ; secretin-like) and 15 in family C (type I11 ; metabotropic glutamate receptor-like).
These families show little or no sequence identity, but all have seven transmembrane domains (7TM proteins).
T h e 65 receptors in family B also fall into three subgroups, all of which share some amino acid sequence in common. T h e ligands determined (so far) have been peptides or small proteins [l] . T h e genes for family B GPCRs have complex, but not identical, structures; many have splice variants. All three subgroups have representatives in the genomes of the fish, worm and fly. This review will highlight some of the more recent developments in our understanding of family B receptors and will focus on bioinformatics-based approaches. At the moment we cannot be certain, but the completion of the first simple chordate and fish genomes should provide an answer. C G R P is a phylogenetically ancient peptide conserved from fish to humans [7] . T h e same applies to calcitonin, but the peptides are less well conserved. T h e calcitonin receptor appears to have diverged more rapidly between species as a result. Adrenomedullin-like immunoreactivity and specific responses have been shown in amphibians and fish, but genes encoding adrenomedullin-like peptides have not been reported in these species. T h e existence of amylin in lower vertebrates is even less clear.
Peptide hormone receptors
T h e peptide hormone receptor group contains promising therapeutic targets. T h e CRF, glucagon-like peptide, C G R P and parathyroid hormone receptors are being considered as targets for depression, diabetes, migraine and bone loss respectively. Small-molecule agonists and antagonists of this type of receptor have been discovered, and the details of some are now being published [8] .
Frizzled and Smoothened receptors
Frizzled receptors (1 0 members) and the Smoothened receptor (one member) show low but significant sequence similarity to the other family B receptors [9] .
Like the ' peptide receptors ', the Frizzled receptors appear to bind their ligands, the Wnts, via their N-termini. T h e Wnts are a class of > 16 vertebrate genes encoding secreted proteins of 350-360 amino acids. In Frizzled receptors the Ntermini are even more cysteine rich, and thus are termed cysteine-rich domains (CRDs). CRDs are also present in distinct gene products that lack the 7 T M domains of Frizzled receptors. Secreted CRDs bind and so sequester Wnts. T h e CRDs have recently been crystallized [lo] . In this state the CRDs dimerize, suggesting interfaces that are complementary and conserved. Receptor dimerization is sometimes obligatory for normal function, but more often is associated with receptor activation. T h e schematics in Figure 1 might be more representative of the 'normal' state if they reflected this (but they are drawn as monomers for the sake of simplicity). T h e concept of equilibrium 475 between ligands, receptors and ligand-binding proteins is well established in endocrinology, but is more often associated with small-molecule ligands than with peptides. T h e family B ligand C R F has a circulating binding protein (that does not resemble the C R F receptor) that competes with the receptor for ligand (like the secreted CRDs). T h e large N-terminal family B (LNB) 7 T M receptors (see below) have N-termini that often contain adhesion domains and can be released, another potential equilibrium.
T [13]. These show no identity with the RAMPs, but suggest parallels between the two types of family B receptors (Figure 1 ). Accessory proteins enable another level of control. There are a large number of Wnt inhibitors, including the CRBs, Cerberus, Dickkopf 1 ( D K K l ) and Wif [14] . Each might be specific for certain Wnts or their pathways. Dickkopf 1 acts to antagonize the association between FR7 and its accessory protein LRP5 (so preventing Wnt activation; Figure 1 ).
LNB 7TM receptors
This class of family B receptors has expanded rapidly since the human genomic sequence became available. Its 33 members are all orphan receptors. Many are still not described outside the patent literature. They all contain a conserved domain in their N-termini, called the GPCR proteolytic site (GPS) domain [15] . At least three LNB 7 T M receptors appear to be cleaved within this site, and it seems probable that they all are [ 16-1 81. Cleavage occurs within the cell, with the N-terminus of the receptor remaining associated, presumably via LNB 7 T M receptors and so provide insight into disulphide bonds between the cysteine residues their function. that lie within the domain. There is evidence to support a further cleavage event that leads to the CD97 family release of the N-terminus (Figure 2 ). T h e nature CD97 is found in white blood cells and is and specificity of the cleavage enzymes remain induced in activated leucocytes. It binds decayunknown. The GPS domain is also found in at accelerating factor (DAF; also termed CD55), a least two other mammalian proteins, the poly-312-amino-acid protein that is expressed on cystic kidney disease ('PCKD') proteins. These most leucocytes and is anchored to their plasma are also multi-transmembrane proteins found at the cell surface, which appear to associate to achieve their biological activities [19] .
Only a few LNB 7 T M receptors have been associated with G-protein signalling. CD97, EGF-like module containing mucin-like receptor (EMR1) and GPR64 will activate the G-proteins GJG, when overexpressed in Xenopus melanophores (C. Jayawickreme, personal communication).
No LNB 7 T M receptor has been paired with its ligand in the conventional sense. However, two proteins occur in Nature that associate tightly with membranes by a glycosylphosphatidylinositol moiety [18, 21] . D A F does not appear to induce G-protein signalling in recombinant systems ( T lymphocytes or H E K cells), but it provides a co-stimulatory signal associated with the activation of the Srcrelated kinase p56Irk. Irrespective of its potential signalling role, DAF itself inactivates complement. Activation of CD97 occurs at sites of inflammation and leads to the measurable release of CD97 N-termini. Since monoclonal antibodies to the N-terminus of D A F neutralize the DAF-CD97 interaction, release of the N-terminus
Figure 2 Protein domains within the N-termini of the LNB 7TM receptor family
The domains were found by searching the current verjions of the Pfam and InterPro motif databases. Dotted lines indicate receptors that are deemed incomplete because we have been unable to convincingly identify a signal sequence. Locus Link IDS were adopted where possible, but the remaining GPCRs are annotated with patent nomenclature in the absence of a more formal system. LRR, leucine-rich repeat; TSP, thrombospondin; CDH, cadherin ~ LAM, laminin; CaB, calcium binding; GPR, G-protein-coupled receptor; CIRL, calciumindependent receptor for latrotoxin; BAI, brain angiogenesis inhibitor; ETL, EGF-IM7-!actrophilin-related protein; CELSR. cadherin. EGF-like, LAG-like, seven pass receptor. Latrophilin family a-Latrotoxin, a 130 kDa component of the venom of the black widow spider, is a powerful secretagogue [4] . It is particularly effective as a toxin because it is targeted towards synapses through an interaction with two types of proteins. Neurexins are neuron-specific proteins with a single transmembrane domain. T h e latrophilins [also known as LECs or calcium-independent receptors for latrotoxin (' CIRLs')] are LNB 7 T M receptors; L E C l and LEC3 are highly enriched in the brain, whereas LEC2 is ubiquitously expressed. Although neurexin la and LECl appear to be the most important receptors for a-latrotoxin, most of the other neurexin and LEC isoforms also constitute functional a-latrotoxin receptors. Experiments on knockout mice lacking neurexin la show that secretion triggered by a-latrotoxin will still occur, but not in the presence of external calcium, so it is clear that neurexin l a has a role in a-latrotoxin activity [23] . A series of studies have shown that a-latrotoxin does not activate L E C l ; for example, it is still effective when the transmembrane domains have been removed. Recent studies on knockout mice lacking L E C l , neurexin la or both proteins have suggested that these proteins normally act in close association. L E C l and neurexin la together account for the majority (75 0 0 ) of a-latrotoxin receptors in brain, with the remaining receptor activity possibly due to other L E C l and neurexin isoforms. As expected, synaptosomes from mice lacking L E C l showed only 25"" of the control response to a-latrotoxin. Surprisingly, synaptosomes from mice lacking both proteins lost only 50 "() of their a-latrotoxin responses. T h e presence of either of the proteins alone appears to lead to the toxin being bound without it being effective. These data suggest that both L E C l and neurexin 477 1 a can bind a-latrotoxin, but their association leads to the toxin being active [23] (Figure 1 ) .
IgG
T h e studies on CD97 and L E C l strongly suggest that there is more to L N B 7 T M receptor signalling than the ligand-induced stabilization of a G-protein-activating state. This is likely to be true for most, if not all, of the LNB 7 T M receptor class. All have the G P S domain and most contain recognized adhesion domains in their N-termini [15]. It is reasonable to think that the N-termini provide a positional context where signalling is re-inforced or suppressed. T h e protein domains within the N-termini of the L N B 7 T M receptor family were found by searching the Pfam and InterPro motif databases (Figure 2 ). Subgroups were defined that contained olfactomedin, E G F , leucine-rich repeat, cadherin or thrombospondin domains. Two of the subgroups contain proteins that do not have any discernible functional domains. Several receptors contain more than one type of domain. T h e very large G-protein-coupled receptors (' VLGRs ') contain a thromobospondin domain as well as multiple NI-/3 (calcium exchange) domains [24] . EMR2 and EMR3 [22, 27] , possibly because they do not exist in the mouse genome or because both genes are within a region that has yet to be sequenced.
T h e pattern of domain structure in the proteins' N-termini follows the phylogeny of the T M regions, suggesting co-evolution. This is not the case for the invertebrate receptors. T h e Caenorhabditis elegans 7 T M domains do not come from a protein that contains the E G F domain which is characteristic of the subgroup in which they have been grouped. However, the mammalian receptors clearly fall into five phylogenetic subgroups with similar domains. A notable exception is the hormone recognition module ( H R M ) domain. There is a protein with a H R M domain in every phylogenetic Figure 3 Phylogenetic tree for the LNB 7TM receptor family Mouse sequences were from public cDNA and peptide databases or from genomic and expressed sequence tag (EST) sequence databases Full-length sequence was unavailable for the mouse orthologues of B4 and p62 I654A Analysis was caried out on partial sequences, leading to extended branch lengths in the phylogeny All the mouse genes clustered with their human orthologues, the species labels are omitted from the figure for ease of viewing The proteins with a HRM domain are denoted with a grey circle Also shown are orthologues from the Coenohobdttts elegons and Drosophtlo melonogoster genomes Two D rnelonogoster and two C elegons genes clustered with the mammalian LNB 7TM recepton, and a D melonogostergene predicted to be a family B 7TM receptor, but not part of the LNB 7TM family, was used as an outgroup ETL. EGF-IM7-!atrophilin-related protein. 
Summary
This review article has sought to emphasize the features that are common to type I1 (or family B) GPCRs. They include sequence, the HRM domain and the evolution of accessory proteins-RAMPS, L R P in Frizzled, D A F and neurexin in CD97 and L E C l . This large group of receptors represents an ancient signalling system that appears to be fundamental to many diverse biological processes. As a result they are attracting interest as therapeutic targets. A greater understanding of their mechanism of activation will improve our ability to validate them as targets and discover ways to enhance or disrupt their activity.
